James R Sowers Selected Research

James R Sowers Research Topics

Disease

85	Insulin Resistance 01/2022 - 02/2002
80	Hypertension (High Blood Pressure) 11/2021 - 06/2002
59	Obesity 01/2022 - 11/2004
55	Fibrosis (Cirrhosis) 10/2021 - 01/2006
46	Inflammation (Inflammations) 01/2022 - 02/2003
37	Type 2 Diabetes Mellitus (MODY) 12/2022 - 07/2002
37	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 06/2002
28	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 02/2002
25	Proteinuria 01/2017 - 02/2002
18	Hypertrophy 12/2017 - 01/2006
14	Kidney Diseases (Kidney Disease) 01/2019 - 04/2008
12	Chronic Renal Insufficiency 11/2021 - 03/2005
11	Albuminuria 01/2021 - 06/2004
11	Dyslipidemias (Dyslipidemia) 01/2021 - 11/2002
10	Hyperglycemia 08/2014 - 07/2002
9	Overnutrition 01/2017 - 01/2011
9	Weight Loss (Weight Reduction) 10/2015 - 10/2003
7	Heart Failure 12/2022 - 07/2009
7	Vascular Remodeling 01/2022 - 09/2009
7	Diabetes Mellitus 11/2021 - 02/2002
7	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 02/2008
6	Body Weight (Weight, Body) 01/2022 - 08/2010
5	Hyperaldosteronism (Conn Syndrome) 01/2019 - 06/2004
5	Left Ventricular Dysfunction 01/2018 - 07/2007
5	Cardiomegaly (Heart Hypertrophy) 10/2017 - 05/2007
5	Non-alcoholic Fatty Liver Disease 01/2016 - 09/2008
5	Hyperinsulinism (Hyperinsulinemia) 03/2013 - 01/2004
5	Glucose Intolerance 06/2009 - 09/2006
5	Atherosclerosis 05/2009 - 01/2004
4	Diabetic Cardiomyopathies 01/2018 - 08/2003
4	Neoplasms (Cancer) 11/2016 - 03/2005
4	Weight Gain 07/2015 - 04/2010
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 03/2015 - 01/2006
4	Stroke (Strokes) 02/2013 - 06/2003
3	Cardiomyopathies (Cardiomyopathy) 10/2021 - 01/2011
3	Metabolic Diseases (Metabolic Disease) 10/2018 - 01/2011
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 04/2004

Drug/Important Bio-Agent (IBA)

67	Insulin (Novolin)FDA Link 01/2022 - 06/2002
36	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 07/2002
30	AldosteroneIBA 01/2022 - 02/2003
28	Angiotensin IIIBA 01/2021 - 06/2002
27	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022 - 06/2008
22	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2015 - 11/2006
20	ReninIBA 06/2013 - 12/2006
18	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2012 - 08/2003
16	Antihypertensive Agents (Antihypertensives)IBA 12/2013 - 01/2004
15	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2007
14	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 02/2003
14	LipidsIBA 01/2020 - 02/2003
11	CytokinesIBA 11/2021 - 01/2004
11	Nebivolol FDA Link 09/2012 - 01/2009
10	CarbohydratesIBA 01/2022 - 04/2008
10	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 07/2008
10	Angiotensin Receptor AntagonistsIBA 10/2021 - 12/2008
10	Oxidants (Oxidizing Agents)IBA 01/2020 - 03/2010
9	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2021 - 02/2002
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 02/2003
9	FructoseIBA 08/2017 - 10/2013
9	3-nitrotyrosineIBA 12/2013 - 02/2007
8	AngiotensinsIBA 04/2014 - 01/2011
8	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 07/2011 - 10/2005
7	Type 1 Angiotensin ReceptorIBA 01/2017 - 12/2006
7	Uric Acid (Urate)IBA 01/2017 - 06/2014
7	AdipokinesIBA 12/2016 - 12/2005
7	SaltsIBA 04/2014 - 06/2004
6	Nitric Oxide Synthase (NO Synthase)IBA 01/2020 - 01/2009
6	CholesterolIBA 01/2016 - 11/2002
6	Hormones (Hormone)IBA 08/2014 - 06/2004
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2008
5	SodiumIBA 10/2019 - 01/2004
5	CollagenIBA 01/2018 - 11/2007
5	CalciumIBA 01/2018 - 03/2005
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 01/2004
5	Metformin (Glucophage)FDA LinkGeneric 10/2015 - 07/2002
5	Rosuvastatin Calcium (Crestor)FDA Link 03/2015 - 05/2007
5	Valsartan (Vals)FDA Link 02/2013 - 02/2005
5	Oxidoreductases (Dehydrogenase)IBA 09/2011 - 12/2007
5	DiureticsIBA 11/2010 - 09/2004
5	Irbesartan FDA LinkGeneric 03/2010 - 10/2005
4	Epithelial Sodium ChannelsIBA 11/2021 - 01/2017
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2021 - 01/2005
4	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2021 - 01/2010
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 07/2002
4	Phosphotransferases (Kinase)IBA 01/2017 - 03/2012
4	MineralocorticoidsIBA 05/2015 - 01/2007
4	Triglycerides (Triacylglycerol)IBA 03/2015 - 12/2003
4	TOR Serine-Threonine KinasesIBA 11/2014 - 01/2011
4	IncretinsIBA 08/2014 - 01/2008
4	LeptinIBA 06/2014 - 01/2004
4	AdiponectinIBA 06/2014 - 12/2005
4	Oxygen (Dioxygen)IBA 10/2013 - 06/2003
4	Serine (L-Serine)FDA Link 04/2013 - 01/2011
4	aliskiren FDA Link 02/2013 - 11/2008
4	Free RadicalsIBA 01/2011 - 06/2003
4	ThiazolidinedionesIBA 08/2010 - 07/2002
3	Mineralocorticoid Receptor AntagonistsIBA 01/2019 - 04/2010
3	Amiloride (Midamor)FDA LinkGeneric 01/2018 - 01/2017

Therapy/Procedure

34	Therapeutics 12/2022 - 06/2002
6	Glycemic Control 01/2018 - 10/2003
5	Bariatric Surgery 04/2013 - 04/2010